Colleagues at the Gladstone and UCSF celebrated the news on Monday that Shinya Yamanaka won the Nobel Prize in Medicine for his discovery that has transformed the field of stem cell research.

Stem cell scientist Shinya Yamanaka, MD, PhD, gained international acclaim in 2006 when he developed the method for inducing skin cells from mice into becoming like pluripotent stem cells and called them iPS cells. Here's a look at his road to the 2012 Nobel Prize in Medicine.

Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes and a UCSF professor of anatomy, is making headlines across the world as winner of the 2012 Nobel Prize in Physiology or Medicine.

Here are answers to frequently asked questions about induced pluripotent stem cells, or iPS cells, the type of cell that has been reprogrammed from an adult cell, such as a skin or blood cell.

Since 1981, when UCSF’s Gail Martin, PhD, co-discovered embryonic stem cells in mice and coined the term embryonic stem cell, UCSF has been a key player in the stem cell field. Today, Shinya Yamanaka became the fifth UCSF scientist to win the Nobel Prize.

Gladstone and UCSF leaders will participate in a Nobel Prize press conference at the Gladstone Institute at 8:30 a.m. Pacific Time (PT). Shinya Yamanaka will join via videoconference from Japan.